DICOM ingest as untrusted input
Preoperative imaging is imported into navigation systems from PACS, USB, and CD - every ingest path must treat the input as untrusted and validate it through the registration step, not just at parse time.
Cybersecurity for image-guided navigation, AR-guided surgery, and intraoperative tracking platforms.
Surgical navigation platforms - cranial, spine, ENT, orthopedic, and the new AR-guided systems - build an intraoperative trust chain from preoperative imaging through registration to real-time tracking and (increasingly) tool actuation. A compromise on the imaging-import path, the registration step, or the tracking telemetry can produce a wrong-site or wrong-trajectory hazard without ever triggering a network alarm. We build cybersecurity packages tuned to the DICOM ingest boundary, the OR-network footprint, and the real-time tracking trust chain that defines this segment.
Preoperative imaging is imported into navigation systems from PACS, USB, and CD - every ingest path must treat the input as untrusted and validate it through the registration step, not just at parse time.
Optical and EM tracking telemetry drives the surgeon's spatial reference - the threat model must enumerate the paths that can spoof, delay, or replay tracking data and validate the system's behavior under each.
Navigation consoles connect to OR-integration towers, intraoperative imaging, and increasingly to robotic platforms - segmentation and inter-device authentication are first-class deliverables.
AR-guided platforms built on consumer-grade headsets inherit the headset OS's update cadence and app-permission model - the SBOM must include the headset stack and the threat model must address the consumer-OS reality.
Surgical-navigation platforms build an intraoperative trust chain from preoperative imaging through registration to real-time tracking. The DICOM ingest path, the tracking telemetry, the OR-integration tower, and (for AR-guided systems) the consumer-OS headset are all in scope.
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
Surgical-navigation incidents are dominated by DICOM ingest and image-management toolkit CVEs, OR-network and integration-tower exposure across capital-equipment categories, and the emerging pattern of AR-headset consumer-OS exposure brought into the OR.
Historical incidents
Published CVEs in widely deployed DICOM parsing and PACS libraries (DCMTK, Orthanc, dcm4che families) repeatedly affect downstream consumers including surgical-navigation platforms. Reviewers expect explicit ingest testing across PACS pull, push, USB, and CD paths, continued through the registration step where tampering produces clinically meaningful effects.
Advisories across OR-integration, imaging, and capital-equipment categories (Steris, Stryker integration platforms, others) demonstrate the recurring exposure pattern when navigation consoles share OR infrastructure with other vendors' systems. Reviewers cite this when evaluating segmentation and inter-device authentication.
AR-guided platforms built on consumer headsets (HoloLens 2 / Magic Leap-class) inherit the headset OS update cadence and app-permission model. Public research on consumer-OS exposure - sideloading, paired-phone abuse, headset-OS background services - informs how the 2026 guidance evaluates AR surgical platforms.
Active threat scenarios
Malformed studies, pixel-data tampering, or substituted volumes pass parse-time validation but produce wrong-trajectory effects at the registration step - the threat model must continue through registration.
Spoofed, delayed, or replayed optical or EM tracking telemetry drives the surgeon's spatial reference and is a direct patient-safety hazard against the IFU's spatial-accuracy claims.
Compromise of an OR-integration tower or co-resident vendor system allows lateral movement to the navigation console - segmentation and inter-device authentication are the controls reviewers expect to see exercised.
Sideloaded apps, headset-OS background services, and paired-phone abuse can affect the AR-guided platform's overlay integrity; SBOM coverage of the headset stack and operational assumptions in the SPDF are required.
What FDA reviewers cite
Surgical navigation builds an intraoperative trust chain from preoperative imaging through registration to real-time tracking - a compromise on any link can produce a wrong-site or wrong-trajectory hazard without triggering a network alarm.
Ingest tampering produces clinically meaningful effects at the registration step, not at parse time - the pen test has to continue through registration, not stop at the DICOM parser.
Optical and EM tracking drives the surgeon's spatial reference; spoofed, delayed, or replayed telemetry is a patient-safety hazard and belongs in the IEC 14971 risk file.
AR-guided platforms inherit the consumer headset's OS update cadence, sideloading, and app-permission model; the SBOM must include the headset stack and the SPDF must state the operational assumptions.
Navigation consoles integrate with intraoperative imaging and increasingly with robotic platforms; inter-device authentication and integration test plans must be explicit in the submission.
Standards & deliverables
Six deliverables FDA and notified bodies expect across MedTech, with the surgical navigation-specific wrinkle on each row. Use it as a scoping checklist before you brief vendors or your QA team.
| Deliverable | Status | Cadence | Standard / guidance | Surgical Navigation note |
|---|---|---|---|---|
| SBOM + VEX Machine-readable SBOM (CycloneDX/SPDX) plus VEX feed for every CVE that touches a listed component. |
Required | Premarket + monthly refresh | FDA Cybersecurity Guidance §V · CISA SBOM minimum elements | SBOM must cover navigation console OS, DICOM libraries, tracking-module firmware (optical/EM), OR-integration tooling, and the AR headset stack where applicable. |
| Postmarket monitoring Continuous CVE / advisory monitoring against the SBOM, with a documented triage and disclosure path. |
Required | Continuous (≤30-day triage) | FD&C Act §524B · FDA Postmarket Cybersecurity Guidance | Continuous monitoring must include DICOM toolkit dependencies and consumer-OS headset platforms with their own update cadence. |
| Penetration test scope Black/grey-box testing across device, wireless interfaces, mobile apps, cloud APIs, and service tooling. |
Required | Premarket + on material change | AAMI TIR57 · FDA Premarket Cyber Guidance §VI.A.5 | Pen test scope: DICOM ingest end-to-end through registration, tracking telemetry spoofing/replay, OR-integration lateral movement, AR-headset consumer-OS abuse paths. |
| Threat model STRIDE-per-interface threat model with documented mitigations and residual-risk acceptance. |
Required | Premarket, refreshed each design change | AAMI TIR57 · FDA Premarket Cyber Guidance §V.A | Treat preoperative imaging, OR-integration towers, and consumer headsets as untrusted inputs; tracking telemetry is safety-critical writable state. |
| Secure update mechanism Signed firmware/software updates with rollback protection, integrity verification, and staged rollout. |
Required | Designed premarket, exercised lifecycle-long | FDA Cyber Guidance §IV · IEC 81001-5-1 | Updates need to work within OR-schedule constraints; AR-headset OS updates require explicit operational assumptions in the SPDF and IFU. |
| Coordinated Vulnerability Disclosure Public CVD policy, intake channel, and SLAs for triage, fix, and customer communication. |
Required | Continuous, lifecycle-long | ISO/IEC 29147 + 30111 · Section 524B(b)(2) | CVD policy must reach OR staff, navigation specialists, and AR-headset platform vendors, with named channels for tracking-integrity reports. |
Machine-readable SBOM (CycloneDX/SPDX) plus VEX feed for every CVE that touches a listed component.
Continuous CVE / advisory monitoring against the SBOM, with a documented triage and disclosure path.
Black/grey-box testing across device, wireless interfaces, mobile apps, cloud APIs, and service tooling.
STRIDE-per-interface threat model with documented mitigations and residual-risk acceptance.
Signed firmware/software updates with rollback protection, integrity verification, and staged rollout.
Public CVD policy, intake channel, and SLAs for triage, fix, and customer communication.
Surgical robotics covers platforms where the system physically actuates instruments under control of a surgeon console. Surgical navigation provides spatial reference and guidance without (typically) actuating tissue - but the integrity of that spatial reference is itself a patient-safety hazard, because a wrong-trajectory or wrong-site outcome can be produced by tampered imaging or spoofed tracking. The threat model has to address imaging-import, registration, and tracking integrity as first-class hazards even when the system doesn't move.
DICOM ingest is exercised as untrusted input across every supported channel - PACS pull, push, USB, CD - with malformed studies, oversized tags, embedded-script abuse, and pixel-data tampering. The pen test continues through the registration step because that's where ingest tampering produces clinically meaningful effects. DICOM Security profile usage is documented where the deployment supports it; where it doesn't, the compensating controls are documented explicitly.
Optical and EM tracking are scoped as safety-critical inputs. The threat model enumerates the paths that can introduce spoofed, delayed, or replayed telemetry (network-attached tracking modules, integration-tower compromise, hostile OR devices) and the system's behavior under each is validated against the IFU's spatial-accuracy claims. Findings tie back to specific hazard entries in the IEC 14971 risk file.
Yes. AR-guided platforms inherit the consumer headset's OS update cadence, app-permission model, and connectivity defaults. The SBOM includes the headset stack, the threat model addresses the consumer-OS reality (sideloaded apps, headset-OS background services, paired-phone abuse), and the SPDF documents the operational assumptions the OR is expected to enforce. The pen test exercises the headset-to-console path and the consumer-OS abuse paths explicitly.
Intraoperative imaging (iCT, O-arm-class) and robotic platforms are scoped as connected components when they share the navigation trust chain. Each interface is enumerated with its protocol, authentication, integrity, and failure mode, and inter-device authentication is verified in the pen test. The SPDF cross-references the integration test plan so the reviewer sees a coherent system.
For a navigation platform with DICOM ingest, intraoperative imaging, and tracking, end-to-end premarket cyber work runs 10-14 weeks. Threat modeling and SBOM front-load in weeks 1-4, pen testing across navigation console, DICOM ingest, tracking, and OR-integration runs in weeks 4-11, and the consolidated submission package closes in the final weeks - all under a written clearance guarantee.
DICOM ingest testing, real-time tracking integrity, OR-integration assessment, and AR-headset consumer-OS hardening review.
"Blue Goat Cyber's depth of expertise was impressive. We had no in-house cybersecurity experience, and their team guided us through every step of the FDA process. The penetration testing and SBOM testing were thorough and gave us complete confidence."
Cybersecurity for image-guided navigation, AR-guided surgery, and intraoperative tracking platforms.